Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, 1081 HV Amsterdam, The Netherlands.
J Biol Chem. 2013 Mar 8;288(10):7169-81. doi: 10.1074/jbc.M112.406108. Epub 2013 Jan 22.
Chemokine receptors form a large subfamily of G protein-coupled receptors that predominantly activate heterotrimeric Gi proteins and are involved in immune cell migration. CCX-CKR is an atypical chemokine receptor with high affinity for CCL19, CCL21, and CCL25 chemokines, but is not known to activate intracellular signaling pathways. However, CCX-CKR acts as decoy receptor and efficiently internalizes these chemokines, thereby preventing their interaction with other chemokine receptors, like CCR7 and CCR9. Internalization of fluorescently labeled CCL19 correlated with β-arrestin2-GFP translocation. Moreover, recruitment of β-arrestins to CCX-CKR in response to CCL19, CCL21, and CCL25 was demonstrated using enzyme-fragment complementation and bioluminescence resonance energy transfer methods. To unravel why CCX-CKR is unable to activate Gi signaling, CCX-CKR chimeras were constructed by substituting its intracellular loops with the corresponding CCR7 or CCR9 domains. The signaling properties of chimeric CCX-CKR receptors were characterized using a cAMP-responsive element (CRE)-driven reporter gene assay. Unexpectedly, wild type CCX-CKR and a subset of the chimeras induced an increase in CRE activity in response to CCL19, CCL21, and CCL25 in the presence of the Gi inhibitor pertussis toxin. CCX-CKR signaling to CRE required an intact DRY motif. These data suggest that inactive Gi proteins impair CCX-CKR signaling most likely by hindering the interaction of this receptor with pertussis toxin-insensitive G proteins that transduce signaling to CRE. On the other hand, recruitment of the putative signaling scaffold β-arrestin to CCX-CKR in response to chemokines might allow activation of yet to be identified signal transduction pathways.
趋化因子受体是 G 蛋白偶联受体的一个大家族,主要激活异三聚体 Gi 蛋白,并参与免疫细胞迁移。CCX-CKR 是一种对 CCL19、CCL21 和 CCL25 趋化因子具有高亲和力的非典型趋化因子受体,但不知道它是否能激活细胞内信号通路。然而,CCX-CKR 作为诱饵受体,有效地将这些趋化因子内化,从而阻止它们与其他趋化因子受体(如 CCR7 和 CCR9)相互作用。荧光标记的 CCL19 的内化与β-arrestin2-GFP 的易位相关。此外,使用酶片段互补和生物发光共振能量转移方法证明了 CCL19、CCL21 和 CCL25 响应时,β-arrestin 向 CCX-CKR 的募集。为了解释为什么 CCX-CKR 不能激活 Gi 信号,通过用相应的 CCR7 或 CCR9 结构域替代其细胞内环,构建了 CCX-CKR 嵌合体。通过 cAMP 反应元件 (CRE) 驱动的报告基因测定,对嵌合 CCX-CKR 受体的信号特性进行了表征。出乎意料的是,野生型 CCX-CKR 和嵌合体的一部分在 Gi 抑制剂百日咳毒素存在的情况下,响应 CCL19、CCL21 和 CCL25,诱导 CRE 活性增加。CCX-CKR 对 CRE 的信号需要一个完整的 DRY 基序。这些数据表明,无活性的 Gi 蛋白很可能通过阻碍该受体与不敏感于百日咳毒素的 G 蛋白相互作用来干扰 CCX-CKR 信号,从而传递信号到 CRE。另一方面,趋化因子响应时,假定的信号支架β-arrestin 向 CCX-CKR 的募集可能允许激活尚未确定的信号转导途径。